Jesse Eisinger

Senior Writer

Jesse Eisinger
By This Author:
« Back
Page 1 of 14
Article

Mad Dash to Nasdaq: Shorts Feel the Pain

By Jesse Eisinger

Short-sellers complain that the market rewards speculation and momentum, not diligence and insight.

01:00PM 12/10/99

Article

Pfizer-Warner Battle Threatens to Derail Lipitor's Runaway Growth

By Jesse Eisinger

A fight over the blockbuster cholesterol drug could end up sabotaging its prospects.

03:00PM 11/30/99

Article

For Sheer Acrimony, Pfizer-Warner Battle Doesn't Measure Up

By Jesse Eisinger

Though the sides have begun sniping at one another, the drugmakers have a long way to go to even get a mention in terms of takeover-inspired hostility.

08:00PM 11/23/99

Article

Drugs and Digs: American Home and Warner Sling a Little Mud

By Jesse Eisinger

A look at the seamier side of the ongoing battle for Warner-Lambert.

07:59PM 11/23/99

Article

Talk-It-Up Tuesday Approaches for Pfizer, Warner-Lambert

By Jesse Eisinger

The press-release salvos come fast and furious.

06:53PM 11/15/99

Article

Suddenly, Pfizer Pfinds Itself in a Tight Spot

By Jesse Eisinger

Less than a week after its record-setting bid for rival Warner-Lambert, the drugmaker is finding Wall Street less than receptive to its point of view.

07:00AM 11/10/99

Article

Pfizer Bid Sours American Home's Sweet Deal

By Jesse Eisinger

A counterbid for Warner-Lambert may well ruin the economics for American Home, analysts say.

07:29PM 11/04/99

Article

Winners and Losers in the American Home, Warner-Lambert Deal

By Jesse Eisinger

Shareholders could end up in either camp, depending on whether this megadeal actually takes place.

08:28PM 11/03/99

Article

Recent Minor Setbacks Obscure Pharmacia's Upside

By Jesse Eisinger

The company doesn't need its drugs to be hugely successful to turn the company around.

12:04PM 11/03/99

Article

Pharmacia Needs Detrol Sales to Grow, but They Seem to Be Stalling

By Jesse Eisinger

And some investors are worried that Alza's competing pee-blocker may be snagging market share from Pharmacia.

12:03PM 11/03/99

« Back
Page 1 of 14

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
Dow Jones S&P 500 NASDAQ 10-Year Note
12,529.75 1,320.68 2,839.38 17.59
Oil *
106.81
UP
33.60
UP
1.82
DOWN
10.74
UP
0.38
10 Yr
1.76%
SPDR Gold
151.41
+0.27%
+0.14%
-0.38%
+2.21%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet